TODD STRATEGY GROUP

Lobbying for ASTELLAS PHARMA US, INC. · Pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · House · Senate · $50,000.00 income · posted Jan 16, 2026

Lobbying activity 2

Pharmacy

Prescription drug pricing.

Health Issues

Prostate cancer screening. Women's health.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem